RespireRx Pharmaceuticals Inc (fka RSPI)

[gfp927z]

Neuro, Nice call on MEMY, from 11-9-08 -

>>> MEMY looks like a buyout/merger candidate to me <<<


>>> Memory Pharma--how a company with what looks like a successful nicotinic partnership with Roche, and an ambiguous partnership with Amgen, can be trading below cash is baffling. It's the Icarus phenomenon--their valuation at one time was bizarrely inflated due to the Kandel/Nobel Prize affiliation. Now they have fallen, and too far. They have some cash but they're burning it: One problem is that they are using money on projects that aren't seen as promising anymore, like PDE4. Even with milestones coming from Roche, the cash only lasts into 2Q:08. Obviously, the delisting process hurt badly. (People don't realize that Cortex being on AMEX has some real advantages at times like this). MEMY looks like a buyout/merger candidate to me, though Roche's ownership of their best asset restricts the range of potential acquirers greatly. <<<